Labcorp Holdings Inc. (LH) is a publicly traded Healthcare sector company. As of May 20, 2026, LH trades at $254.87 with a market cap of $20.96B and a P/E ratio of 22.31. LH moved +0.39% today. Year to date, LH is +0.81%; over the trailing twelve months it is +1.56%. Its 52-week range spans $209.38 to $293.72. Analyst consensus is strong buy with an average price target of $310.78. Rallies surfaces LH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes LH SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $254.87 |
| Market Cap | $20.96B |
| P/E Ratio | 22.31 |
| EPS | $11.36 |
| Dividend Yield | 0.72% |
| 52-Week High | $293.72 |
| 52-Week Low | $209.38 |
| Volume | 135.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.14B |
| Net Income | $942.70M |
| Gross Margin | 28.83% |
10 analysts cover LH: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $310.78.